HIV Diagnosis Market Analysis

HIV Diagnosis Industry Insights

Product Analysis

The consumables category accounted for the largest HIV diagnosis market share, of 60% in 2024, and it will also witness the highest CAGR during the forecast period. This is mainly attributable to the increasing use of reagents, assays, and kits for laboratory as well as home-based analytical tests. In addition, consumables need to be procured continuously and repetitively by hospitals and labs. Furthermore, the surge in the number of initiatives taken by government organizations to combat the spread of AIDS is expected to drive the category during the forecast period.

These products are part of the research scope:

• Consumables (Largest and Fastest-Growing Category)
• Instruments
• Software & Services

Test Type Analysis

Based on type, the antibody test category garnered the largest market size in 2024, driven by the increasing number of approvals for new antibody tests with higher sensitivity and specificity by various regulatory authorities globally, including the USFDA. In addition, the surging pace of technological advancements and rising awareness regarding the disease are driving the demand for such tests. Further, the increasing adoption of these tests in countries such as Malaysia, India, Thailand, and China is fueling the category’s growth. Moreover, most recent antibody tests, including the confirmatory Western blot test, are considered over 99% precise.

Early infant diagnosis is the fastest-growing category, with a CAGR of 10.5%. This is because of the increasing awareness of the transmission of HIV to the baby from the mother in utero. The WHO says that almost 1.3 million females living with HIV conceive each year across the globe. There is a 15–45% chance that they will pass on the infection to the infant during pregnancy, breastfeeding, delivery, or labor. This is why HIV testing is becoming an important aspect of prenatal care. For instance, New Zealand offers free HIV tests to pregnant women along with other antenatal blood tests for blood group & Rh factor, hepatitis B, TLC/DLC, syphilis, and rubella. Moreover, in countries with high transmission rates, the WHO, UNICEF, and other international agencies are taking initiatives to make people aware of these tests and make them accessible to he masses.

We studied these test types:

• Antibody Test (Largest Category)
  • HIV-1 Screening Test
    • ELISA
    • Rapid Test
    • Home Access Dried Blood Spot
  • HIV-1 Antibody Confirmatory Test
    • Western Blot
    • Indirect Immune Fluorescent Antibody Assay (IFA)
    • Line Immunoassay (LIA)
    • Radio-Immunoprecipitation Assay (RIPA)
  • HIV-2 & Group O Test
    • Blood Antibody Test
    • Dried Blood Spot (DBS) Test
    • Others
• Viral Load
• CD4
• Early Infant Diagnosis (Fastest-Growing Category)
• Viral Identification

Diagnostic Laboratories To Witness Highest CAGR

Hospitals dominate the market with 45% share in 2024. Most patients prefer hospitals because these places are all-inclusive centers that offer comprehensive care. Patients can trust hospitals to provide the highest levels of services, inclusive of diagnosis, prognosis, prophylaxis, and palliative care. Tertiary-care hospitals generally house comprehensive diagnostics laboratories with advanced equipment and employ skilled doctors for consultation and treatment.

The diagnostic laboratories category is expected to register the highest CAGR in the forecast period. Diagnostic laboratories are one of the major end users of these analytical instruments and kits. In countries where people do not have access to portable analytical kits, such labs are the mainstay of the virus detection ecosystem.

Furthermore, the advent of new, portable devices for diagnosis has led to the increasing affordability of these products for diagnostic laboratories, which, in turn, is resulting in a greater number of people being diagnosed with the disease. These labs offer the advantage of the latest instruments, as well as skilled professionals who can perform various tests to screen and confirm the presence of the infection.

These end users have been analyzed:

• Diagnostic Laboratories (Fastest-Growing Category)
• Hospitals (Largest Category)
• Homecare Settings
• Others